RaQualia Pharma Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4,440	3,240	3,340	3,714	3,675	2,345
Short-Term Investments	54	3	1	49	250	313
Cash & Short-Term Investments	4,494	3,243	3,341	3,763	3,925	2,658
Cash Growth	62.57%	-2.93%	-11.21%	-4.13%	47.67%	25.79%
Receivables	1,234	1,928	689	603	602	1,205
Inventory	161	159	167	147	8	10
Prepaid Expenses	439	165	193	188	108	90
Other Current Assets	154	187	148	255	179	40
Total Current Assets	6,482	5,682	4,538	4,956	4,822	4,003
Property, Plant & Equipment	439	436	529	573	391	299
Long-Term Investments	746	598	607	1,306	1,020	897
Goodwill	3,630	3,700	3,865	-	-	-
Other Intangible Assets	30	32	37	30	24	33
Long-Term Deferred Tax Assets	63	64	78	5	-	-
Other Long-Term Assets	1	2	1	1	-	2
Total Assets	11,391	10,514	9,655	6,871	6,257	5,234
Accounts Payable	63	73	59	54	128	45
Accrued Expenses	56	58	69	54	60	63
Current Portion of Long-Term Debt	512	512	512	12	2	-
Current Portion of Leases	85	78	69	64	42	21
Current Income Taxes Payable	196	320	221	178	237	230
Other Current Liabilities	140	234	257	27	24	41
Total Current Liabilities	1,052	1,275	1,187	389	493	400
Long-Term Debt	2,010	2,138	2,651	39	9	-
Long-Term Leases	179	171	218	251	167	17
Long-Term Deferred Tax Liabilities	-	-	-	-	2	16
Other Long-Term Liabilities	65	35	28	73	89	15
Total Liabilities	3,306	3,619	4,084	752	760	448
Common Stock	3,947	3,240	2,720	2,667	2,265	2,256
Additional Paid-In Capital	4,137	3,430	2,910	2,857	2,455	2,446
Retained Earnings	1	227	-45	449	773	49
Comprehensive Income & Other	-	-2	-14	146	4	35
Shareholders' Equity	8,085	6,895	5,571	6,119	5,497	4,786
Total Liabilities & Equity	11,391	10,514	9,655	6,871	6,257	5,234
Total Debt	2,786	2,899	3,450	366	220	38
Net Cash (Debt)	1,708	344	-109	3,397	3,705	2,620
Net Cash Growth	-	-	-	-8.31%	41.41%	26.69%
Net Cash Per Share	68.39	14.30	-5.04	157.22	176.57	124.93
Filing Date Shares Outstanding	25.53	26.02	21.84	21.62	21.6	20.96
Total Common Shares Outstanding	25.53	24.46	21.84	21.62	20.98	20.95
Working Capital	5,430	4,407	3,351	4,567	4,329	3,603
Book Value Per Share	316.65	281.91	255.10	282.98	262.05	228.43
Tangible Book Value	4,425	3,163	1,669	6,089	5,473	4,753
Tangible Book Value Per Share	173.31	129.32	76.43	281.60	260.90	226.86